BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 18553894)

  • 1. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
    Zintchenko A; Philipp A; Dehshahri A; Wagner E
    Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly efficient siRNA carrier of PBLG modified hyperbranched PEI.
    Chen J; Tian H; Guo Z; Xia J; Kano A; Maruyama A; Jing X; Chen X
    Macromol Biosci; 2009 Dec; 9(12):1247-53. PubMed ID: 19890950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.
    Wang J; Dou B; Bao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
    Jiang G; Park K; Kim J; Kim KS; Hahn SK
    Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of disulfide-linked and hydrophobically-modified PEI for plasmid delivery.
    Remant Bahadur KC; Uludağ H
    J Biomater Sci Polym Ed; 2011; 22(7):873-92. PubMed ID: 20573316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-related off-target effects in non-viral siRNA delivery.
    Merkel OM; Beyerle A; Beckmann BM; Zheng M; Hartmann RK; Stöger T; Kissel TH
    Biomaterials; 2011 Mar; 32(9):2388-98. PubMed ID: 21183213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine.
    Shim MS; Kwon YJ
    J Control Release; 2009 Feb; 133(3):206-13. PubMed ID: 18992289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.
    Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H
    Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acyl chain length on transfection efficiency and toxicity of polyethylenimine.
    Aravindan L; Bicknell KA; Brooks G; Khutoryanskiy VV; Williams AC
    Int J Pharm; 2009 Aug; 378(1-2):201-10. PubMed ID: 19501146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
    Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
    Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
    Huang HY; Kuo WT; Chou MJ; Huang YY
    J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfection efficiency of 25-kDa PEI-cholesterol conjugates with different levels of modification.
    Gusachenko Simonova O; Kravchuk Y; Konevets D; Silnikov V; Vlassov VV; Zenkova MA
    J Biomater Sci Polym Ed; 2009; 20(7-8):1091-110. PubMed ID: 19454171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.